Agency Information Collection Activities: Proposed Collection; Comment Request, 58664-58666 [2021-23107]
Download as PDF
58664
Federal Register / Vol. 86, No. 202 / Friday, October 22, 2021 / Notices
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children program, along
with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the CDC Director and
appear on CDC immunization schedules
must be covered by applicable health
plans.
Matters To Be Considered: The agenda
will include discussions on adult
immunization schedule, child/
adolescent immunization schedule,
Ebola vaccine, hepatitis vaccines,
Orthopoxviruses vaccine and COVID
vaccines. Recommendation votes on
adult immunization schedule, child/
adolescent immunization schedule,
hepatitis vaccine, Orthopoxviruses
vaccine, Ebola vaccine and COVID
vaccines are scheduled. No Vaccines for
Children votes are scheduled. Agenda
items are subject to change as priorities
dictate. For more information on the
meeting agenda visit https://
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: The docket
will be opened to receive written
comments on October 22, 2021. Written
VerDate Sep<11>2014
17:47 Oct 21, 2021
Jkt 256001
comments must be received on or before
November 3, 2021.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the November 2–3,
2021 ACIP meeting must submit a
request at https://www.cdc.gov/vaccines/
acip/meetings/ no later than 11:59 p.m.,
EDT, October 31, 2021, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by November 1, 2021. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–23222 Filed 10–20–21; 4:15 pm]
BILLING CODE 4163–18–P
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–2567, CMS–
10790 and CMS–10463]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 21, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
SUMMARY:
E:\FR\FM\22OCN1.SGM
22OCN1
Federal Register / Vol. 86, No. 202 / Friday, October 22, 2021 / Notices
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
lotter on DSK11XQN23PROD with NOTICES1
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–2567 Statement of Deficiency
and Plan of Correction
CMS–10790 Medicare-Funded GME
Residency Positions in accordance
with Section 126 of the Consolidated
Appropriations Act, 2020 (Pub. L.
116–93)
CMS–10463 Cooperative Agreement to
Support Navigators in Federallyfacilitated Exchanges
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Statement of
Deficiency and Plan of Correction Use:
The form CMS–2567 is the means by
which State and CMS surveyors
document findings of compliance or
noncompliance (deficiencies) resulting
from inspection of Medicare, Medicaid,
and Clinical Laboratory Improvement
Amendments (CLIA) laboratories. The
VerDate Sep<11>2014
17:47 Oct 21, 2021
Jkt 256001
form CMS–2567 is the legal,
documentary basis for CMS’
certification of a facility’s compliance or
noncompliance with the Medicare/
Medicaid Conditions of Participation or
Coverage, and the requirements for
Nursing Home participation and CLIA
certification.
In December, 2020, Congress passed
the Consolidated Appropriations Act,
2021 (CAA, 2021). Section 407 of CAA,
2021, amended Part A of Title XVIII of
the Social Security Act (the Act) at
section 1822 establishing hospice
program survey and enforcement
requirements. This amendment, in part,
now requires the Accrediting
Organizations (AOs) that accredit
hospice programs to include the form
CMS–2567 to document the findings of
their hospice program surveys
beginning on October 1, 2021. As of
June 2021, there are three AOs with
CMS-approved hospice accreditation
programs. The AOs survey
approximately half of the over 5,000
Medicare-certified hospice programs,
while the SAs survey the remaining
half. Form Numbers: CMS–2567 (OMB
control number: 0938–0391); Frequency:
Yearly and Occasionally; Affected
Public: Private Sector (Business or forprofits and Not-for-profit institutions);
Number of Respondents: 65,948; Total
Annual Responses: 65,948; Total
Annual Hours: 1,187,064. (For policy
questions regarding this collection
contact Caroline Gallaher at 410–786–
8705.)
2. Type of Information Collection
Request: New collection (Request for a
new OMB Control Number); Title of
Information Collection: MedicareFunded GME Residency Positions in
accordance with Section 126 of the
Consolidated Appropriations Act, 2020
(Pub. L. 116–93); Use: The requirements
in this rule were announced in CMS–
1752–P (FY22 IPPS); however, the PRA
package has been under development
until now. The plan, approved by OMB
and CM, is to have the 60-day publish
and then have CMS–1752–F2 serve as
the 30-day notice, with the goal of
approval in early January 2022.
Section 126 of the Consolidated
Appropriations Act (CAA), 2021 (Pub.
L. 116–93), enacted December 20, 2020,
included a key provision affecting
Medicare payments for Graduate
Medical Education (GME). Section
126(a) of the CAA amended section
1886(h) of the Act by adding a new
section 1886(h)(9) requiring the
distribution of additional residency
positions (slots) to qualifying hospitals.
Section 1886(h)(9)(A) makes an
additional 1,000 Medicare funded
residency slots available to be phased in
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
58665
beginning in FY 2023 until the aggregate
number of 1,000 full-time equivalent
residency positions are distributed.
This approval request is for CMS to
receive electronic applications for
Medicare-Funded GME Residency
Positions submitted in accordance with
Section 126 of the Consolidated
Appropriations Act, 2021. The
electronic applications will be
submitted by the applicants in CMS’
new Medicare Electronic Application
Request Information SystemTM
(MEARISTM). There is no existing, hard
copy version of the application. The
applications will provide CMS with the
critical information necessary for CMS
to process and score the applications in
accordance with the policies finalized
in the upcoming final rule to determine
the disbursement of the slots and to
announce the awardees by the January
31, 2023 required statutory deadline.
Form Number: CMS–10790 (OMB
control number: 0938–NEW);
Frequency: Yearly; Affected Public:
Private sector (Business or other forprofits and Not-for-profit institutions),
State, Local, or Tribal Governments;
Number of Respondents: 1,325; Total
Annual Responses: 1,325; Total Annual
Hours: 10,600. (For policy questions
regarding this collection contact Noel
Manlove at 410–786–5161.)
3. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Cooperative
Agreement to Support Navigators in
Federally-facilitated Exchanges; Use:
Section 1311(i) of the PPACA requires
Exchanges to establish a Navigator grant
program under which it awards grants
to eligible individuals and entities (as
described in Section 1311(i)(2) of the
PPACA and 45 CFR 155.210(a) and (c))
applying to serve consumers in States
with a FFE. Navigators assist consumers
by providing education about and
facilitating selection of qualified health
plans (QHPs) within the Exchanges, as
well as other required duties. Entities
and individuals cannot serve as
federally certified Navigators and carry
out the required duties without
receiving federal cooperative agreement
funding. On July 1, 2021, HHS
published the Updating Payment
Parameters, Section 1332 Waiver
Implementing Regulations, and
Improving Health Insurance Markets for
2022 and Beyond Proposed Rule
proposed rule. The proposed regulations
would amend federal regulations at 45
CFR 155.210(e)(9) to reinstitute the
requirement that FFE Navigators
provide consumers with information
and assistance on access, affordability
and certain post-enrollment topics, such
E:\FR\FM\22OCN1.SGM
22OCN1
58666
Federal Register / Vol. 86, No. 202 / Friday, October 22, 2021 / Notices
as the eligibility appeals process, the
Exchange-related components of the
Premium Tax Credit (PTC)
reconciliation process, and the basic
concepts and rights of health coverage
and how to use it.
Under the Terms and Conditions of
the Navigator program cooperative
agreements, awardees must provide
progress reports on a weekly, monthly,
quarterly and annual basis during the
cooperative agreement period of
performance, and a final report at the
end of the period of performance.
Awardees will submit their progress
reports electronically to CMS staff for
evaluation and analysis. The results of
this evaluation will provide feedback on
the effectiveness of the Navigator
program, so that HHS and CMS
leadership may evaluate the
effectiveness of the program and address
any areas that need revisions. CMS will
also use the information collected from
Navigator grant awardees to inform the
public about the availability of
application and enrollment assistance
services from designated organizations.
Form Number: CMS–10463 (OMB
control number: 0938–1215); Frequency:
Annually, Monthly, Quarterly, Weekly;
Affected Public: Private sector; Number
of Respondents: 100; Total Annual
Responses: 5,200; Total Annual Hours:
529,000. (For questions regarding this
collection contact Gian Johnson at 301–
492–4323.)
Dated: October 19, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–23107 Filed 10–21–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0559]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Public Health
Service Guideline on Infectious
Disease Issues in Xenotransplantation
AGENCY:
Food and Drug Administration,
HHS.
lotter on DSK11XQN23PROD with NOTICES1
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
SUMMARY:
VerDate Sep<11>2014
17:47 Oct 21, 2021
Jkt 256001
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to this notice. This notice
solicits comments on the collection of
information contained in the Public
Health Service (PHS) guideline entitled
‘‘PHS Guideline on Infectious Disease
Issues in Xenotransplantation.’’
DATES: Submit either electronic or
written comments on the collection of
information by December 21, 2021.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before December 21,
2021. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of December 21, 2021.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2012–N–0559 for ‘‘PHS Guideline on
Infectious Disease Issues in
Xenotransplantation.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
E:\FR\FM\22OCN1.SGM
22OCN1
Agencies
[Federal Register Volume 86, Number 202 (Friday, October 22, 2021)]
[Notices]
[Pages 58664-58666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23107]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-2567, CMS-10790 and CMS-10463]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by December 21, 2021.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
[[Page 58665]]
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-2567 Statement of Deficiency and Plan of Correction
CMS-10790 Medicare-Funded GME Residency Positions in accordance with
Section 126 of the Consolidated Appropriations Act, 2020 (Pub. L. 116-
93)
CMS-10463 Cooperative Agreement to Support Navigators in Federally-
facilitated Exchanges
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Statement of
Deficiency and Plan of Correction Use: The form CMS-2567 is the means
by which State and CMS surveyors document findings of compliance or
noncompliance (deficiencies) resulting from inspection of Medicare,
Medicaid, and Clinical Laboratory Improvement Amendments (CLIA)
laboratories. The form CMS-2567 is the legal, documentary basis for
CMS' certification of a facility's compliance or noncompliance with the
Medicare/Medicaid Conditions of Participation or Coverage, and the
requirements for Nursing Home participation and CLIA certification.
In December, 2020, Congress passed the Consolidated Appropriations
Act, 2021 (CAA, 2021). Section 407 of CAA, 2021, amended Part A of
Title XVIII of the Social Security Act (the Act) at section 1822
establishing hospice program survey and enforcement requirements. This
amendment, in part, now requires the Accrediting Organizations (AOs)
that accredit hospice programs to include the form CMS-2567 to document
the findings of their hospice program surveys beginning on October 1,
2021. As of June 2021, there are three AOs with CMS-approved hospice
accreditation programs. The AOs survey approximately half of the over
5,000 Medicare-certified hospice programs, while the SAs survey the
remaining half. Form Numbers: CMS-2567 (OMB control number: 0938-0391);
Frequency: Yearly and Occasionally; Affected Public: Private Sector
(Business or for-profits and Not-for-profit institutions); Number of
Respondents: 65,948; Total Annual Responses: 65,948; Total Annual
Hours: 1,187,064. (For policy questions regarding this collection
contact Caroline Gallaher at 410-786-8705.)
2. Type of Information Collection Request: New collection (Request
for a new OMB Control Number); Title of Information Collection:
Medicare-Funded GME Residency Positions in accordance with Section 126
of the Consolidated Appropriations Act, 2020 (Pub. L. 116-93); Use: The
requirements in this rule were announced in CMS-1752-P (FY22 IPPS);
however, the PRA package has been under development until now. The
plan, approved by OMB and CM, is to have the 60-day publish and then
have CMS-1752-F2 serve as the 30-day notice, with the goal of approval
in early January 2022.
Section 126 of the Consolidated Appropriations Act (CAA), 2021
(Pub. L. 116-93), enacted December 20, 2020, included a key provision
affecting Medicare payments for Graduate Medical Education (GME).
Section 126(a) of the CAA amended section 1886(h) of the Act by adding
a new section 1886(h)(9) requiring the distribution of additional
residency positions (slots) to qualifying hospitals. Section
1886(h)(9)(A) makes an additional 1,000 Medicare funded residency slots
available to be phased in beginning in FY 2023 until the aggregate
number of 1,000 full-time equivalent residency positions are
distributed.
This approval request is for CMS to receive electronic applications
for Medicare-Funded GME Residency Positions submitted in accordance
with Section 126 of the Consolidated Appropriations Act, 2021. The
electronic applications will be submitted by the applicants in CMS' new
Medicare Electronic Application Request Information SystemTM
(MEARISTM). There is no existing, hard copy version of the
application. The applications will provide CMS with the critical
information necessary for CMS to process and score the applications in
accordance with the policies finalized in the upcoming final rule to
determine the disbursement of the slots and to announce the awardees by
the January 31, 2023 required statutory deadline. Form Number: CMS-
10790 (OMB control number: 0938-NEW); Frequency: Yearly; Affected
Public: Private sector (Business or other for-profits and Not-for-
profit institutions), State, Local, or Tribal Governments; Number of
Respondents: 1,325; Total Annual Responses: 1,325; Total Annual Hours:
10,600. (For policy questions regarding this collection contact Noel
Manlove at 410-786-5161.)
3. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Cooperative
Agreement to Support Navigators in Federally-facilitated Exchanges;
Use: Section 1311(i) of the PPACA requires Exchanges to establish a
Navigator grant program under which it awards grants to eligible
individuals and entities (as described in Section 1311(i)(2) of the
PPACA and 45 CFR 155.210(a) and (c)) applying to serve consumers in
States with a FFE. Navigators assist consumers by providing education
about and facilitating selection of qualified health plans (QHPs)
within the Exchanges, as well as other required duties. Entities and
individuals cannot serve as federally certified Navigators and carry
out the required duties without receiving federal cooperative agreement
funding. On July 1, 2021, HHS published the Updating Payment
Parameters, Section 1332 Waiver Implementing Regulations, and Improving
Health Insurance Markets for 2022 and Beyond Proposed Rule proposed
rule. The proposed regulations would amend federal regulations at 45
CFR 155.210(e)(9) to reinstitute the requirement that FFE Navigators
provide consumers with information and assistance on access,
affordability and certain post-enrollment topics, such
[[Page 58666]]
as the eligibility appeals process, the Exchange-related components of
the Premium Tax Credit (PTC) reconciliation process, and the basic
concepts and rights of health coverage and how to use it.
Under the Terms and Conditions of the Navigator program cooperative
agreements, awardees must provide progress reports on a weekly,
monthly, quarterly and annual basis during the cooperative agreement
period of performance, and a final report at the end of the period of
performance. Awardees will submit their progress reports electronically
to CMS staff for evaluation and analysis. The results of this
evaluation will provide feedback on the effectiveness of the Navigator
program, so that HHS and CMS leadership may evaluate the effectiveness
of the program and address any areas that need revisions. CMS will also
use the information collected from Navigator grant awardees to inform
the public about the availability of application and enrollment
assistance services from designated organizations. Form Number: CMS-
10463 (OMB control number: 0938-1215); Frequency: Annually, Monthly,
Quarterly, Weekly; Affected Public: Private sector; Number of
Respondents: 100; Total Annual Responses: 5,200; Total Annual Hours:
529,000. (For questions regarding this collection contact Gian Johnson
at 301-492-4323.)
Dated: October 19, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2021-23107 Filed 10-21-21; 8:45 am]
BILLING CODE 4120-01-P